HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
Go back to HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results
March 20, 2024 4:41 AM EDT
BofA Securities analyst Allen Lutz raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $97.00 (from $93.00) while maintaining a Buy rating.
The analyst comments "HealthEquity reported a strong quarter, with strong expense management in Technology & Development the largest upside driver versus our model. FY25 revenue and EBITDA guidance was in line... More
March 20, 2024 4:11 AM EDT
BTIG analyst David Larsen raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $110.00 (from $100.00) while maintaining a Buy rating.
The analyst comments "On Tuesday, 3/19/24 AMC, HQY reported excellent F4Q:24 results. Total revenue of $262.4M +12% y/y exceeded BTIG / consensus estimates of $260.7M / $258.7M and adjusted EBITDA of $98.8M +34% y/y also exceeded BTIG / consensus estimates of $98M / $91.5M. HQY re-affirmed revenue guidance for... More
March 19, 2024 4:03 PM EDT
HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.63, $0.07 better than the analyst estimate of $0.56. Revenue for the quarter came in at $262.4 million versus the consensus estimate of $258.31 million.
GUIDANCE:
HealthEquity sees FY2025 EPS of $2.79-$2.96, versus the consensus of $2.84. HealthEquity sees... More
